Rockefeller Capital Management L.P. boosted its stake in BlackRock Health Sciences Term Trust (NYSE:BMEZ – Free Report) by 62.6% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 118,445 shares of the company’s stock after buying an additional 45,616 shares during the quarter. Rockefeller Capital Management L.P.’s holdings in BlackRock Health Sciences Term Trust were worth $1,706,000 at the end of the most recent quarter.
A number of other large investors have also recently bought and sold shares of BMEZ. Jane Street Group LLC bought a new position in shares of BlackRock Health Sciences Term Trust during the third quarter valued at $357,000. Raymond James Financial Inc. bought a new position in BlackRock Health Sciences Term Trust during the 4th quarter valued at about $10,869,000. Corient Private Wealth LLC boosted its position in BlackRock Health Sciences Term Trust by 24.9% in the fourth quarter. Corient Private Wealth LLC now owns 26,225 shares of the company’s stock valued at $378,000 after buying an additional 5,224 shares in the last quarter. Commonwealth Equity Services LLC grew its stake in BlackRock Health Sciences Term Trust by 3.7% during the fourth quarter. Commonwealth Equity Services LLC now owns 102,437 shares of the company’s stock worth $1,475,000 after buying an additional 3,635 shares during the last quarter. Finally, Wolverine Asset Management LLC increased its holdings in shares of BlackRock Health Sciences Term Trust by 496.1% during the fourth quarter. Wolverine Asset Management LLC now owns 187,617 shares of the company’s stock worth $2,702,000 after buying an additional 156,141 shares in the last quarter.
BlackRock Health Sciences Term Trust Price Performance
Shares of BMEZ opened at $13.64 on Monday. BlackRock Health Sciences Term Trust has a one year low of $12.58 and a one year high of $16.75. The business’s 50 day simple moving average is $14.96 and its 200-day simple moving average is $15.35.
BlackRock Health Sciences Term Trust Cuts Dividend
BlackRock Health Sciences Term Trust Profile
BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.
Recommended Stories
- Five stocks we like better than BlackRock Health Sciences Term Trust
- How to Invest in the FAANG Stocks
- With a 60%+ Upside, There’s Plenty to Love About Lovesac
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- J.B. Hunt Transport Overcorrects Into a Buying Opportunity
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- AppLovin: Can Record Profits Overcome Market Skepticism?
Receive News & Ratings for BlackRock Health Sciences Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.